5-179032861-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000444149.7(ZNF879):āc.913A>Gā(p.Asn305Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000179 in 1,565,126 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000444149.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF879 | NM_001136116.3 | c.913A>G | p.Asn305Asp | missense_variant | 5/5 | ENST00000444149.7 | NP_001129588.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF879 | ENST00000444149.7 | c.913A>G | p.Asn305Asp | missense_variant | 5/5 | 1 | NM_001136116.3 | ENSP00000414887 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000504 AC: 9AN: 178516Hom.: 0 AF XY: 0.0000845 AC XY: 8AN XY: 94642
GnomAD4 exome AF: 0.0000184 AC: 26AN: 1412788Hom.: 1 Cov.: 32 AF XY: 0.0000258 AC XY: 18AN XY: 698126
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.913A>G (p.N305D) alteration is located in exon 5 (coding exon 4) of the ZNF879 gene. This alteration results from a A to G substitution at nucleotide position 913, causing the asparagine (N) at amino acid position 305 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at